Key result
Angiotensin-(1-7) increased ANP secretion at high atrial pacing via the Mas/PI3K/Akt pathway and attenuated isoproterenol-induced cardiac hypertrophy in a rat model.
Why the study?
Does Angiotensin-(1-7) stimulate ANP secretion and attenuate cardiac hypertrophy in rat models?
Does Angiotensin-(1-7) stimulate ANP secretion and attenuate cardiac hypertrophy in rat models?
Answers are grounded in this paper and cite their sources.
ANG-(1-7) stimulates ANP secretion during high atrial pacing and attenuates cardiac hypertrophy, suggesting a therapeutic mechanism mediated by ANP.
Angiotensin-(1-7) [ANG-(1-7)], one of the bioactive peptides produced in the renin-angiotensin system, plays a pivotal role in cardiovascular physiology by providing a counterbalance to the function of ANG II. Recently, it has been considered as a potential candidate for therapeutic use in the treatment of various types of cardiovascular diseases. The aim of the present study is to explain the modulatory role of ANG-(1-7) in atrial natriuretic peptide (ANP) secretion and investigate the functional relationship between two peptides to induce cardiovascular effects using isolated perfused beating rat atria and a cardiac hypertrophied rat model. ANG-(1-7) (0.01, 0.1, and 1 muM) increased ANP secretion and ANP concentration in a dose-dependent manner at high atrial pacing (6.0 Hz) with increased cGMP production. However, at low atrial pacing (1.2 Hz), ANG-(1-7) did not cause changes in atrial parameters. Pretreatment with an antagonist of the Mas receptor or with inhibitors of phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), or nitric oxide synthase blocked the augmentation of high atrial pacing-induced ANP secretion by ANG-(1-7). A similar result was observed with the inhibition of the Na(+)/H(+) exchanger-1 and Ca(2+)/calmodulin-dependent kinase II (CaMKII). ANG-(1-7) did not show basal intracellular Ca(2+) signaling in quiescent atrial myocytes. In an in vivo study using an isoproterenol-induced cardiac hypertrophy animal model, an acute infusion of ANG-(1-7) increased the plasma concentration of ANP by twofold without changes in blood pressure and heart rate. A chronic administration of ANG-(1-7) increased the plasma ANP level and attenuated isoproterenol-induced cardiac hypertrophy. The antihypertrophic effect was abrogated by a cotreatment with the natriuretic peptide receptor-A antagonist. These results suggest that 1) ANG-(1-7) increased ANP secretion at high atrial pacing via the Mas/PI3K/Akt pathway and the activation of Na(+)/H(+) exchanger-1 and CaMKII and 2) ANG-(1-7) decreased cardiac hypertrophy which might be mediated by ANP.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2010) studied Cardiac hypertrophy (animal model). Angiotensin-(1-7) vs. Control / isoproterenol alone was evaluated on ANP secretion and cardiac hypertrophy. Angiotensin-(1-7) increased ANP secretion at high atrial pacing via the Mas/PI3K/Akt pathway and attenuated isoproterenol-induced cardiac hypertrophy in a rat model.
Synapse has enriched 10 related papers. Consider them for comparative context: